NewsBenzingaOptimizeRx 第三季度调整后每股收益 0.20 美元,超出 0.17 美元预期;销售额 2161.5 万美元,超出 2118.8 万美元预期 OptimizeRx 第三季度调整后每股收益 0.20 美元,超出 0.17 美元预期;销售额 2161.5 万美元,超出 2118.8 万美元预期 Benzinga 2026.11.11 21:02 (GMT+0) Open on Benzinga Other news StoneX Maintains Buy on Rivian Automotive, Lowers Price Target to $20 Amer Sports Unleashes $1 Billion Buyback, Raises 2026 Outlook EXCLUSIVE: Tesla Still Rules Leveraged ETFs, but Anthropic IPO and Micron’s Rise Signal What’s Next StoneX Reiterates Hold on iQIYIto Hold StoneX Maintains Buy on Baidu, Lowers Price Target to $125 Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide
Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide